Treatment Side Effects and Strategies for Managing Them: Trodelvy
In the fight against breast cancer, a new drug called Trodelvy (sacituzumab govitecan-hziy) has been making waves. This medication is primarily used for advanced or metastatic triple-negative breast cancer or HR-positive, HER2-negative breast cancer after previous treatments.
Trodelvy is administered by intravenous infusion under medical supervision, which allows for close monitoring and management of potential adverse effects.
Common side effects of Trodelvy include mild nausea and vomiting, diarrhea, fatigue, hair loss, constipation, abdominal pain, rash, anorexia, weight loss, swelling of limbs, mucositis, QT interval prolongation, and myelosuppression.
Milder side effects, often overlapping with common ones, include gastrointestinal symptoms, hair thinning or hair loss, fatigue, rash or skin irritation, constipation or mild abdominal pain.
However, it's important to be aware of the serious side effects as well. Trodelvy can increase the risk of severe neutropenia, a condition characterised by very low neutrophils, a type of white blood cell. This increases the risk of infections, some of which can be life-threatening.
Other serious side effects include severe diarrhea, severe nausea and vomiting, myelosuppression-related severe infections or bleeding, heart-related effects such as QT prolongation, potentially severe infusion reactions or allergic responses, and elevated liver function tests.
It's crucial to note that Trodelvy carries boxed warnings about the risks of diarrhea and low levels of certain white blood cells.
Before starting Trodelvy treatment, inform your doctor about any medical conditions or medications you're taking. If you have an allergic reaction to Trodelvy or any of its ingredients, your doctor may not prescribe the drug.
Hair loss was a common side effect reported in clinical trials for Trodelvy. To help manage this, your doctor may give you certain medications before your infusion. For example, they may recommend using an over-the-counter drug, such as minoxidil (Rogaine), to help reduce hair loss.
Your doctor will monitor your white blood cell levels throughout your Trodelvy treatment. If your neutrophil levels become too low, your doctor may recommend decreasing your Trodelvy dose or taking another drug to increase your neutrophil levels.
If you develop symptoms of infection, such as fever or chills, shortness of breath, burning or pain while urinating, cough, or wounds that won't heal, report them to your doctor immediately.
If you develop an infusion-related reaction, symptoms can include trouble breathing, itching, decreased blood pressure, swelling of your face, lips, or tongue, skin rash or hives, heart attack, and other symptoms. If this occurs, call your doctor or go to a hospital right away.
Trodelvy is not safe to receive during pregnancy or while breastfeeding. Due to any possible risks to your child, your doctor will not recommend breastfeeding during Trodelvy treatment and for at least 1 month after the end of your treatment.
If you experience hair loss during your treatment with Trodelvy, talk with your doctor. They may be able to provide advice or support to help you manage this side effect.
For males, it's recommended to use birth control if you have a partner who can become pregnant and for at least 3 months after your Trodelvy treatment ends.
In summary, while Trodelvy can be an effective treatment option for certain types of breast cancer, it's important to be aware of its side effect profile and precautions. Close monitoring and supportive care are crucial in managing potential adverse effects. Always discuss any concerns with your healthcare provider.
- Trodelvy is primarily used for advanced or metastatic triple-negative breast cancer or HR-positive, HER2-negative breast cancer after previous treatments.
- Hair loss was a common side effect reported in clinical trials for Trodelvy, and your doctor may give you certain medications before your infusion to help manage this.
- Trodelvy carries boxed warnings about the risks of diarrhea and low levels of certain white blood cells, and it's crucial to note these risks.
- If you have an allergic reaction to Trodelvy or any of its ingredients, your doctor may not prescribe the drug.
- It's important to be aware of the serious side effects of Trodelvy, which include severe neutropenia, severe diarrhea, severe nausea and vomiting, myelosuppression-related severe infections or bleeding, heart-related effects such as QT prolongation, potentially severe infusion reactions or allergic responses, and elevated liver function tests.
